Matrixyl vs Melanotan II — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Matrixyl is the trade name for Palmitoyl Pentapeptide-4 (Pal-KTTKS), developed by Sederma (now Croda). It is derived from a procollagen type I C-terminal propeptide fragment and uses palmitoylation to cross the skin lipid barrier and reach dermal fibroblasts....
Calculate Matrixyl dose →Melanotan II (MT-II) is a synthetic analog of alpha-MSH (alpha-melanocyte-stimulating hormone) that non-selectively activates melanocortin receptors MC1R through MC5R. It produces accelerated skin tanning via MC1R stimulation of melanogenesis, increases libido through MC3R and MC...
Calculate Melanotan II dose →| Parameter | Matrixyl | Melanotan II |
|---|---|---|
| Category | Skin & Cosmetic | Skin & Cosmetic |
| Research | Widely Used (Cosmetic) | Research Use |
| Half-Life | - | ~1.5 hours |
| Typical Dose | 3–5% in formulation | 250–500 µg (starting); up to 1,000 µg |
| Frequency | Twice daily | Daily initially; 2–3x/week maintenance |
| Route | Topical | Subcutaneous |
| FDA Status | Not Approved (Cosmetic) | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.